translocations or amplifications on top of the genomic alterations presently existing in the original CLL, but deficiency the prevalent mutations observed in Major DLBCL indicating that they may perhaps correspond to a special biological classification.Are BTK and PLCG2 mutations necessary and sufficient for ibrutinib resistance in Persistent lymph